Drug intelligence / Profile preview

(S)-2-amino-3-(1,3,5,7-pentahydro-2,4-dioxo-cyclopenta[e]pyrimidin-1-yl)propanoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

(S)-2-amino-3-(1,3,5,7-pentahydro-2.4-dioxo-cyclopenta[e]pyrimidin-l-yI)propanoic acid is a synthetic small molecule structurally related to amino acids and pyrimidine derivatives. It is primarily used as an experimental tool compound in biochemical and pharmacological research. The compound has been studied for its interaction with glutamate receptors—specifically the GluR subtypes—where it acts as a ligand or modulator in receptor binding studies[8]. Its mechanism of action involves mimicking or interfering with endogenous amino acid neurotransmitters at excitatory synapses.

Other names
(S)-2-Amino-3-(1,3,5,7-Pentahydro-2-4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid(2S)-2-amino-3-{2,4-dioxo-1H,2H,3H,4H,5H,6H,7H-cyclopenta[d]pyrimidin-1-yl}propanoic acidL-alanine 3-(2,3,4,5,6,7-hexahydro-2.4-dioxo-lh-cyclopenta[d]pyrimidin-l-yI)
02

Targets

GRIA2 (AMPA receptor subunit GluA2)

Beyond the preview

Go deeper on (S)-2-amino-3-(1,3,5,7-pentahydro-2,4-dioxo-cyclopenta[e]pyrimidin-1-yl)propanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-2-amino-3-(1,3,5,7-pentahydro-2,4-dioxo-cyclopenta[e]pyrimidin-1-yl)propanoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call